# Acerus Pharmaceuticals Corp: Form D filings

Acerus Pharmaceuticals Corp, a pharmaceuticals company in Mississauga, Ontario, Canada, filed 3 Form D notices with the SEC between 2011 and 2016. The latest, on May 5, 2016, reports $2 million sold of a $2 million offering to 1 investor.

Find out what Acerus Pharmaceuticals Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Acerus%20Pharmaceuticals%20Corp%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Acerus%20Pharmaceuticals%20Corp&page=%2Fdata%2Fform-d%2Fcompany%2Facerus-pharmaceuticals-corp-1527246)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Acerus%20Pharmaceuticals%20Corp%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Acerus%20Pharmaceuticals%20Corp&page=%2Fdata%2Fform-d%2Fcompany%2Facerus-pharmaceuticals-corp-1527246)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 2486 DUNWIN DRIVE, Mississauga, Ontario, Canada, L5L 1
- Phone: (416) 679-0771
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Ontario, Canada
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1527246

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 5, 2016 | New notice | $2,000,000 | $2,000,000 | $0 | 1 | Apr 27, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1527246/000121465916011258/0001214659-16-011258-index.htm) |
| Aug 13, 2014 | New notice | $2,131,268 | $2,131,268 | $0 | 2 | Jul 30, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1527246/000114036114032106/0001140361-14-032106-index.htm) |
| Aug 3, 2011 | New notice | $12,026,355 | $6,847,846 | $5,178,509 | 16 | Jul 14, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1527246/000120919111042167/0001209191-11-042167-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| MATTHEW K. HAWKINS | Executive Officer |  |
| IAN IHNATOWYCZ | Director |  |
| BORYS K. CHABURSKY | Director |  |
| ROLF K. REININGHAUS | Director |  |
| TOM K. ROSSI | Executive Officer, Director |  |
| JEFFREY K. SHERMAN | Director |  |
| DR. NATHAN K. BRYSON | Executive Officer |  |
| DR. MICHAEL K. BUMBY | Executive Officer |  |
| STEPHEN GREGORY | Director |  |
| JOSEF K. VEJVODA | Director |  |
| NORMA BEAUCHAMP | Director |  |

[Every Form D from the week of May 2, 2016](https://specstream.ai/data/form-d/week/2016-05-02) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Acerus Pharmaceuticals Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).